Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Circulating insulin-like growth factor I (IGF-I) is positively associated with the risks of colorectal, breast, and prostate cancer, but evidence for other less common cancers is limited. In this study, we investigated associations between serum IGF-I concentrations and incidence of less common cancers in the UK Biobank study. To enable comparison of effect estimates, and as positive controls, both common and less common cancer sites (total 30) were included in an outcome-wide analysis. Data from 394,388 cancer-free participants in the UK Biobank study were analyzed. Multivariable adjusted Cox proportional hazards models were used to determine associations between baseline serum IGF-I concentrations and cancer incidence, using repeated IGF-I measurements from up to 14,149 participants to correct for regression dilution bias. Higher IGF-I concentration was associated with increased risks of thyroid cancer [HR per 5 nmol/L higher concentration 1.18; 95% confidence interval (CI), 1.01–1.37] in addition to colorectal (HR, 1.08; 95% CI, 1.03–1.13), breast (HR, 1.11; 95% CI, 1.07–1.15), and prostate cancer (HR, 1.08; 95% CI, 1.05–1.12), and reduced risks of ovarian and liver cancer. Mean follow-up was 6.9 years and the possibility that the observed associations may be influenced by reverse causality bias cannot be excluded. Additional nominally significant associations with malignant melanoma, multiple myeloma, oral cancer, and esophageal squamous cell carcinoma did not survive correction for multiple testing. Studies with longer follow-up and pooled analyses are needed to further assess how broad the role of IGF-I is in cancer development. Significance: The results from this outcome-wide analysis are consistent with a positive association of IGF-I with cancers at several sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979 · cited 16×
“This research has been conducted using theUKBiobankResource under application number 24494.”
BackgroundResultInfluentialWhat makes UK Biobank special?
Collins, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60404-8 · Cited by 1,128
The Impact of Residual and Unmeasured Confounding in Epidemiologic Studies: A Simulation Study
Fewell, Z., Davey Smith, G., & Sterne, J. A. C. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm165 · Cited by 734
Batty, G. D., Gale, C. R., Kivimäki, M., Deary, I. J., & Bell, S. (2020) · BMJ · doi:10.1136/bmj.m131 · Cited by 635 · cited 1×
“5%), which raises the risk of selection bias; however, it has been shown that despite a favorable risk profile and lower incidence of cancer in UK Biobank (28) risk factor–endpoint associations are comparable with those found in nationally representative studies with average response rates of 68% (53).”
ResultInsulin-Like Growth Factor (IGF) System in Liver Diseases
Adamek, A., & Kasprzak, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051308 · Cited by 284 · cited 1×
“Case–control studies suggest that low serum IGF-I concentrations might be caused by decreased hepatic reserve in nonalcoholic fatty liver disease, liver cirrhosis, and hepatocellular carcinoma (39).”
Background
Cited by
Insulin-like growth factors: Ligands, binding proteins, and receptors
LeRoith, D., Holly, J. M. P., & Forbes, B. E. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101245 · Cited by 303
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Kasprzak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126434 · Cited by 248
Papier, K., Atkins, J. R., Tong, T. Y. N., Gaitskell, K., Desai, T., Ogamba, C. F., Parsaeian, M., Reeves, G. K., Mills, I. G., Key, T. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48017-6 · Cited by 97
Self-citationMatsoukas, M.-T., Radomsky, T., Panagiotopoulos, V., Preez, R. D., Papadourakis, M., Tsianakas, K., Millar, R. P., Anderson, R. C., Spyroulias, G. A., & Newton, C. L. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00577 · Cited by 4
Metadata
- Authors
- Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., Perez-Cornago, A., Schmidt, J. A., Smith Byrne, K., Travis, R. C., & Key, T. J.
- Venue
- Cancer Research
- Published
- 2020-09-15
- Volume
- 80
- Issue
- 18
- Pages
- 4014-4021
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W3043978031
- Cited by
- 96
- References
- 6
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank. https://app.cochat.ai/papers/10.1158/0008-5472.can-20-1281
- The paper
- Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., Perez-Cornago, A., Schmidt, J. A., Smith Byrne, K., Travis, R. C., & Key, T. J. (2020). Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank. Cancer Research. https://doi.org/10.1158/0008-5472.can-20-1281
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.